Cargando…

Platelet Function Analyzer-200 P2Y Results Are Predictive of the Risk of Major Adverse Cardiac Events in Korean Patients Receiving Clopidogrel Therapy Following Acute Coronary Syndrome

BACKGROUND: Clopidogrel is one of the most commonly used anti-platelet agents in cardiovascular diseases. We analyzed the relationship between the platelet function analyzer (PFA)-200 P2Y (INNOVANCE PFA-200 System, Siemens Healthcare, Germany) results and occurrence of major adverse cardiac events (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Hyeon-Ho, Li, Shuhua, An, Gyu-Dae, Woo, Kwang-Sook, Kim, Kyeong-Hee, Kim, Jeong-Man, Kim, Moo-Hyun, Han, Jin-Yeong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Laboratory Medicine 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973914/ https://www.ncbi.nlm.nih.gov/pubmed/29797810 http://dx.doi.org/10.3343/alm.2018.38.5.413

Ejemplares similares

Investigation of Platelet Function Analyzer 200 platelet function measurements in healthy cats and cats receiving clopidogrel
por: Kornya, Matthew R., et al.
Publicado: (2023)

Correlation Between the CYP2C19 Phenotype Status and the Results of Three Different Platelet Function Tests in Cardiovascular Disease Patients Receiving Antiplatelet Therapy: An Emphasis on Newly Introduced Platelet Function Analyzer-200 P2Y Test
por: Li, Shuhua, et al.
Publicado: (2016)

Comparison of Multiplate, Platelet Function Analyzer‐200, and Plateletworks in Healthy Dogs Treated with Aspirin and Clopidogrel
por: Saati, S., et al.
Publicado: (2017)

Comparison of Triple Anti-Platelet Therapy (Aspirin, Clopidogrel, and Cilostazol) and Double Anti-Platelet Therapy (Aspirin and Clopidogrel) on Platelet Aggregation in Type 2 Diabetic Patients Undergoing Drug-Eluting Stent Implantation
por: Yang, Tae-Hyun, et al.
Publicado: (2009)

The role of platelet function analyzer-200 in predicting perioperative bleeding risk
por: Yu, Eun Sang, et al.
Publicado: (2020)

Randomized Comparison of the Platelet Inhibitory Efficacy between Low Dose Prasugrel and Standard Dose Clopidogrel in Patients Who Underwent Percutaneous Coronary Intervention
por: Jin, Han-Young, et al.
Publicado: (2014)

NUP98 Rearrangement in Acute Myelomonocytic Leukemia With t(11;19)(p15;p12): The First Case Report Worldwide
por: Lim, Hyeon-Ho, et al.
Publicado: (2017)

Evaluation of neutrophil extracellular traps as the circulating marker for patients with acute coronary syndrome and acute ischemic stroke
por: Lim, Hyeon‐Ho, et al.
Publicado: (2020)

Analyzing the Korean reference genome with meta-imputation increased the imputation accuracy and spectrum of rare variants in the Korean population
por: Hwang, Mi Yeong, et al.
Publicado: (2022)

A Rare Case of Acute Myeloid Leukemia With SET-NUP214 Fusion and Massive Hyperdiploidy
por: Jeong, In Hwa, et al.
Publicado: (2019)

Association Between Prolonged Closure Time on the Platelet Function Analyzer-200 and Risk of Perioperative Blood Transfusion
por: Jeon, Kibum, et al.
Publicado: (2019)

Temporal Variability of Platelet Reactivity in Patients Treated with Clopidogrel or Ticagrelor
por: Yun, Kyeong Ho, et al.
Publicado: (2019)

Effects of Cilostazol on Platelet Activation in Coronary Stenting Patients Who Already Treated with Aspirin and Clopidogrel.
por: Ahn, Jeong Cheon, et al.
Publicado: (2004)

Genetic determinants of platelet response to clopidogrel
por: Kubica, Aldona, et al.
Publicado: (2011)

Impact of Platelet Function Test on Platelet Responsiveness and Clinical Outcome After Coronary Stent Implantation: Platelet Responsiveness and Clinical Outcome
por: Yu, Long Hao, et al.
Publicado: (2012)

Mutations at codons 178, 200-129, and 232 contributed to the inherited prion diseases in Korean patients
por: Choi, Bo-Yeong, et al.
Publicado: (2009)

Comparison of prasugrel and clopidogrel reloading on high platelet reactivity in clopidogrel-loaded patients undergoing percutaneous coronary intervention (PRAISE-HPR): a study protocol for a prospective randomized controlled clinical trial
por: Lee, Dong-Hyun, et al.
Publicado: (2013)

CD200 Change Is Involved in Neuronal Death in Gerbil Hippocampal CA1 Field Following Transient Forebrain Ischemia and Postischemic Treatment with Risperidone Displays Neuroprotection without CD200 Change
por: Lee, Tae-Kyeong, et al.
Publicado: (2021)

Genomewide Association Study of Platelet Reactivity and Cardiovascular Response in Patients Treated With Clopidogrel: A Study by the International Clopidogrel Pharmacogenomics Consortium
por: Verma, Shefali Setia, et al.
Publicado: (2020)

The association between higher FFAs and high residual platelet reactivity among CAD patients receiving clopidogrel therapy
por: Zhao, Zehao, et al.
Publicado: (2023)

Variants in clopidogrel-relevant genes and early neurological deterioration in ischemic stroke patients receiving clopidogrel
por: Yi, Xingyang, et al.
Publicado: (2020)

An Assay of Measuring Platelet Reactivity Using Monoclonal Antibody against Activated Platelet Glycoprotein IIb/IIIa in Patients Taking Clopidogrel
por: Joo, Seung-Jae, et al.
Publicado: (2015)

Inability to Reverse Aspirin and Clopidogrel-induced Platelet Dysfunction with Platelet Infusion
por: Cohn, Stephen M, et al.
Publicado: (2019)

Platelet Reactivity and Response to Aspirin and Clopidogrel in Patients with Platelet Count Disorders
por: Kuliczkowski, Wiktor, et al.
Publicado: (2021)

Comparison of Clopidogrel and Ticlopidine/Ginkgo Biloba in Patients With Clopidogrel Resistance and Carotid Stenting
por: Chung, Jong-Won, et al.
Publicado: (2019)

Clinical, Pharmacokinetic, and Pharmacogenetic Determinants of Clopidogrel Resistance in Korean Patients with Acute Coronary Syndrome
por: Park, Kyoung-Jin, et al.
Publicado: (2011)

The Trajectory of Iliac Screw in the Axial Plane in 200 Korean Patients
por: Shin, Jae-Hyuk, et al.
Publicado: (2010)

Effects of clopidogrel and prednisone on platelet function in healthy dogs
por: Thomason, John, et al.
Publicado: (2020)

Association of lipoprotein(a) with intrinsic and on-clopidogrel platelet reactivity
por: Kille, Alexander, et al.
Publicado: (2021)

Effects of omeprazole or pantoprazole on platelet function in non-ST-segment elevation acute coronary syndrome patients receiving clopidogrel
por: Gu, Ruo-Xi, et al.
Publicado: (2016)

Corrigendum: The association between higher FFAs and high residual platelet reactivity among CAD patients receiving clopidogrel therapy
por: Zhao, Zehao, et al.
Publicado: (2023)

Adjunctive Cilostazol versus High Maintenance Dose of Clopidogrel in Patients with Hyporesponsiveness to Chronic Clopidogrel Therapy
por: Lee, Ga Yeon, et al.
Publicado: (2013)

Clinical significance of high on-treatment platelet reactivity in patients with prolonged clopidogrel therapy
por: Kim, Sehun, et al.
Publicado: (2021)

A retrospective analysis of cytogenetic alterations in patients with newly diagnosed multiple myeloma: a single center study in Korea
por: Li, Shuhua, et al.
Publicado: (2016)

The Impact of Smoking on Post-Clopidogrel Platelet Reactivity in Patients With Acute Myocardial Infarction
por: Cho, Jung-Hyun, et al.
Publicado: (2010)

Application of genomic big data to analyze the genetic diversity and population structure of Korean domestic chickens
por: Cho, Eunjin, et al.
Publicado: (2023)

Influence of individual proton pump inhibitors on clinical outcomes in patients receiving clopidogrel following percutaneous coronary intervention
por: Lee, Dongyoung, et al.
Publicado: (2021)

Elevated serum C1q is an independent predictor of high residual platelet reactivity in CAD patients receiving clopidogrel therapy
por: Zhao, Zehao, et al.
Publicado: (2022)

Thrombocytopenia Induced by Clopidogrel: A Rare Adverse Effect
por: Távora, Catarina, et al.
Publicado: (2023)

Anti-platelet role of Korean ginseng and ginsenosides in cardiovascular diseases
por: Irfan, Muhammad, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g59bhj7854pafugs7ujeqlk7gd